Meanwhile, in our corhort, we also validated the independent predictabilities for disease-free survival from the well-known clinical variables for tumor aggressiveness including AFP, microvascular invasion, and tumor size, and those variables for impaired liver function including hepatitis B, ALT, and albumin. The gene discussed is ALB; the disease is neoplasm.